IV Vitamin C
When you look at the evidence with IV Vitamin C, the volume dwarfs much of the research that pushes many prescriptions drugs today. The published evidence for the benefit of IV Vitamin C in cancer includes a reduction in pain, decreased cancer-associated inflammation, prevents cancer-associated sepsis, reduces side effects and toxicity of chemotherapy and radiation, augments the cancer kill rate of chemotherapy and radiation, and kills cancer stem cells (CSC). However, IV Vitamin C is not created equally for all cancers and is not a one-size-fits-all approach. The patient size, tumor burden (amount of cancer present), metastasis or spread of cancer, the type of cancer, the aggressiveness of cancer, and whether the cancer is the primary presenting tumor or is recurrent all play a role in determining the dose and the frequency of the Vitamin C.
The Best 64 Alternative Cancer Treatment Centers that offer IV Vitamin C
How IV Vitamin C works
What Research Says about IV Vitamin C
There is still controversy surrounding IV vitamin C, but many studies support the use of IV vitamin C in cancer.
Preclinical studies have shown high dose ascorbic acid (IV C) to have cytotoxic effects (kill or damage) in cancer cells. Furthermore, high-dose ascorbic acid (IV C) is shown to be tolerable in conjunction with some chemotherapies, improve the quality of life, and reduce chemotherapy-induced side effects in cancer patients.
Although promising, there is still a need for ongoing research on high-dose ascorbic acid (IV C) and cancer.
History of IV Vitamin C
In 1932 Albert Szent-Gyorgyia, a Hungarian biochemist discovered a 6-carbon carbohydrate, hexuronic acid, and named it "ascorbic acid" due to its anti-scorbutic properties.
Later, Dr. William McCormick observed that cancer patients deficient in vitamin C often presented survey-like symptoms and hypothesized that vitamin c might protect against cancer because vitamin C increases collagen synthesis.
Then in 1972, Ewan Cameron, a Scottish Surgeon hypothesized that a high dose of vitamin C could suppress the development and metastasis of cancer. He then began treating terminally ill cancer patients with vitamin C and published a case report in which 50 patients benefited from a high dose of Vitamin C.
In 1976 Ewan Cameron and Linus Pauling teamed up to publish another study involving IV vitamin C, followed by oral supplementation of C in 100 terminal cancer patients. They compared the results to 1000 similar cases receiving identical cancer treatments but no C supplementation. They found that patients using C had a survival rate four times that of those not receiving C.
Another study was published shortly after by the Mayo Clinic, which failed to show any positive effects of Vitamin C and cancer. Although more rigorous than the Cameron-Pauling Trial, there were significant differences between the two studies. For example, the Mayo Clinic switched to chemotherapy when patients developed tumor progression and stopped the C. Another important difference was that the Mayo Clinics study was 2.5 years, while the Cameron-Pauling trial lasted over 12 years. The most crucial difference to note was that the Mayo Clinic gave 10 grams orally daily, while the Cameron-Pauling trial gave both oral and intervenous C.
Risks / Side Effects of IV Vitamin C
Although rare IV Vitamin C can cause:
- Gastrointestinal upset
- Kidney Stones
- Hemolytic Anemia
- Low Blood Sugar
- Low Blood Pressure
Anti-Cancer Benefits of IV Vitamin C
IV C has been shown to reduce chemotherapy-induced side effects such as fatigue weight loss and general quality of life. Preclinical studies have shown high dose ascorbic acid (IV C) to have cytotoxic effects (kill or damage) in cancer cells.
IV Vitamin C is used in Treatments for
What to Expect
How is it given?
IV vitamin C is typically given intravenously typically in a clinical setting.
Other Names for Treatment
Average Price of Treatment
$99 - $400
Patients receive between 7 and 75 grams of vitamin C, but dosing varies depending on the patient.
References of IV Vitamin C